Man Group
IONS icon

Man Group’s Ionis Pharmaceuticals IONS Stock Holding History

Man Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$980K Sell
12,361
-11,652
-49% -$877K ﹤0.01% 1865
2026
Q1 		$1.8M Sell
24,013
-142,029
-86% -$11.2M ﹤0.01% 1613
2025
Q4 		$13.1M Sell
166,042
-167,778
-50% -$12.6M 0.02% 668
2025
Q3 		$21.8M Buy
333,820
+324,851
+3,622% +$15.9M 0.04% 479
2025
Q2 		$354K Sell
8,969
-1,064
-11% -$34.8K ﹤0.01% 1924
2025
Q1 		$303K Buy
10,033
+1,718
+21% +$56.3K ﹤0.01% 1931
2024
Q4 		$291K Sell
8,315
-587,948
-99% -$22M ﹤0.01% 1800
2024
Q3 		$23.9M Sell
596,263
-37,146
-6% -$1.73M 0.06% 391
2024
Q2 		$30.2M Buy
633,409
+380,188
+150% +$15.6M 0.08% 299
2024
Q1 		$11M Buy
253,221
+174,746
+223% +$8.33M 0.03% 664
2023
Q4 		$3.97M Buy
+78,475
New +$3.76M 0.01% 1052
2023
Q3 		– Hold
0
– – – 740
2023
Q1 		– Sell
-230,525
Closed -$8.66M – 592
2022
Q4 		$8.71M Buy
230,525
+52,928
+30% +$2.23M 0.03% 629
2022
Q3 		$7.86M Buy
+177,597
New +$7.48M 0.04% 565
2022
Q2 		– Hold
0
– – – 1600
2020
Q4 		– Sell
-6,204
Closed -$294K – 1877
2020
Q3 		$294K Sell
6,204
-109,808
-95% -$6.1M ﹤0.01% 1636
2020
Q2 		$6.84M Buy
116,012
+106,312
+1,096% +$5.91M 0.03% 522
2020
Q1 		$459K Sell
9,700
-48,970
-83% -$2.73M ﹤0.01% 1293
2019
Q4 		$3.54M Buy
58,670
+4,422
+8% +$263K 0.01% 1122
2019
Q3 		$3.25M Sell
54,248
-28,707
-35% -$1.87M 0.01% 1071
2019
Q2 		$5.33M Buy
82,955
+62,031
+296% +$4.38M 0.02% 922
2019
Q1 		$1.7M Buy
20,924
+15,800
+308% +$1.02M 0.01% 1400
2018
Q4 		$277K Sell
5,124
-6,953
-58% -$355K ﹤0.01% 1750
2018
Q3 		$623K Sell
12,077
-6,032
-33% -$283K ﹤0.01% 1792
2018
Q2 		$755K Buy
18,109
+13,509
+294% +$599K ﹤0.01% 1685
2018
Q1 		$203K Buy
+4,600
New +$234K ﹤0.01% 1920

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Man Group's IONS Position: Q2 2026 in Review

Man Group reduced its Ionis Pharmaceuticals (IONS) stake by 49% in Q2 2026, selling an estimated $877K and leaving 12,361 shares worth $980K. The position accounts for ﹤0.01% of the portfolio, ranked #1865.

Man Group first reported a position in IONS in Q1 2018 and has held it in 24 quarters since. The position peaked at $30.2M in Q2 2024. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Man Group held 12,361 shares of Ionis Pharmaceuticals worth $980K as of Q2 2026.
  • Man Group sold 11,652 Ionis Pharmaceuticals shares in Q2 2026, an estimated $877K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1865 holding.
  • Man Group first reported a position in Ionis Pharmaceuticals in Q1 2018 and has held it in 24 quarters since.
  • Man Group's Ionis Pharmaceuticals position peaked at $30.2M in Q2 2024.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.